HomeProductsBioactive CompoundsCell CyclePPARMuraglitazar
Chemical structure of CAS 331741-94-7

Muraglitazar

In Stock•Starting at $367 for 1 mg
CAS No.331741-94-7
MDL No.MFCD20270627
MFC29H28N2O7
MW516.50
InChI KeyIRLWJILLXJGJTD-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$367In Stock
5 mgTo Be Confirmed$902In Stock
10 mgTo Be Confirmed$1287In Stock
25 mgTo Be Confirmed$1843In Stock
50 mgTo Be Confirmed$2577In Stock
100 mgTo Be Confirmed$3472In Stock
500 mgTo Be Confirmed$6963In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Muraglitazar is a 1,3-oxazole derivative.

CAS No.331741-94-7
Product NameMuraglitazar

Biological Targets

PPARA·PPARG

Associated Conditions

Disorder of lipid metabolism·diabetes mellitus·type 2 diabetes mellitus
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

JAMA • Vol. 294, Issue 20 • 2005
PMID: 16239637DOI: 10.1001/jama.294.20.joc50147

Selling safety--lessons from muraglitazar.

JAMA • Vol. 294, Issue 20 • 2005
PMID: 16239638DOI: 10.1001/jama.294.20.jed50074

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.

Cardiovascular diabetology • Vol. 4 • 2005
PMID: 16168052PMC: PMC1236941DOI: 10.1186/1475-2840-4-14

Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.

Journal of medicinal chemistry • Vol. 48, Issue 6 • 2005
PMID: 15771468DOI: 10.1021/jm0496436

Documentation

Similar Products